BioCentury
ARTICLE | Company News

Celltech to evaluate Evotec technology

April 10, 2001 7:00 AM UTC

Evotec (NMarkt:EVT) and Celltech (LSE:CCH; CLL) entered into an evaluation agreement under which EVT will apply its VLiP (virus-like particle) cellular assay technology to two G protein-coupled recept...